跳至主要内容
临床试验/TCTR20240509001
TCTR20240509001已完成不适用

Evaluation of Renal Function in Patients with Atrial Fibrillation received Warfarin compared with Aspirin

/A0 个研究点目标入组 360 人开始时间: 2024年5月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
30 Years 至 95 Years(—)
性别
All

入选标准

  • Patients diagnosed with Atrial Fibrillation (AF) who received treatment from
  • 1 January 2020 to 31 March 2023, regardless of age and gender. and was treated with Warfarin and Aspirin.

排除标准

  • Patients with co-morbidities that have the potential to cause kidney complications or kidney deterioration, such as
  • Systemic Lupus Erythematosus (SLE), Autoimmune Disease, Uncontrolled Hypertension, Uncontrolled Diabetes Mellitus, Uncontrolled Hyperlipidemia

研究者

发起方
/A

相似试验